Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus

NCT01677013 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1026

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

OTHER: BMMCT

Sponsor

Peking University Aerospace Center Hospital